CN109275903A - 适用于男性和女性的性保健食品 - Google Patents
适用于男性和女性的性保健食品 Download PDFInfo
- Publication number
- CN109275903A CN109275903A CN201710597992.4A CN201710597992A CN109275903A CN 109275903 A CN109275903 A CN 109275903A CN 201710597992 A CN201710597992 A CN 201710597992A CN 109275903 A CN109275903 A CN 109275903A
- Authority
- CN
- China
- Prior art keywords
- parts
- health food
- sexual health
- magnesium
- sexual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 70
- 230000035911 sexual health Effects 0.000 title claims abstract description 69
- 235000021028 berry Nutrition 0.000 claims abstract description 35
- 210000000582 semen Anatomy 0.000 claims abstract description 27
- 240000004371 Panax ginseng Species 0.000 claims abstract description 26
- 235000008434 ginseng Nutrition 0.000 claims abstract description 26
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 23
- 241000005787 Cistanche Species 0.000 claims abstract description 22
- 241000241627 Pfaffia Species 0.000 claims abstract description 19
- 239000010018 saw palmetto extract Substances 0.000 claims abstract description 18
- 240000006661 Serenoa repens Species 0.000 claims abstract description 17
- 235000005318 Serenoa repens Nutrition 0.000 claims abstract description 17
- 240000000143 Turnera diffusa Species 0.000 claims abstract description 17
- 235000004952 turnera diffusa Nutrition 0.000 claims abstract description 17
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 claims abstract description 14
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 14
- 241001533104 Tribulus terrestris Species 0.000 claims abstract description 12
- 150000002515 isoflavone derivatives Chemical class 0.000 claims abstract description 10
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 8
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 8
- 240000007890 Leonurus cardiaca Species 0.000 claims abstract 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 17
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 16
- 239000011777 magnesium Substances 0.000 claims description 16
- 229910052749 magnesium Inorganic materials 0.000 claims description 16
- 235000001055 magnesium Nutrition 0.000 claims description 16
- 229940091250 magnesium supplement Drugs 0.000 claims description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 12
- 229960005069 calcium Drugs 0.000 claims description 12
- 229910052791 calcium Inorganic materials 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 10
- 239000011701 zinc Substances 0.000 claims description 10
- 229910052725 zinc Inorganic materials 0.000 claims description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 229960004203 carnitine Drugs 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- RWYRUDPAALLKPX-UHFFFAOYSA-N 2,2-difluoro-n-methylethanamine;hydrochloride Chemical compound Cl.CNCC(F)F RWYRUDPAALLKPX-UHFFFAOYSA-N 0.000 claims description 5
- 239000001749 Calcium fumarate Substances 0.000 claims description 5
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims description 5
- 229940024606 amino acid Drugs 0.000 claims description 5
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 235000019296 calcium fumarate Nutrition 0.000 claims description 5
- 239000004471 Glycine Substances 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 4
- 239000004337 magnesium citrate Substances 0.000 claims description 4
- 229960005336 magnesium citrate Drugs 0.000 claims description 4
- 235000002538 magnesium citrate Nutrition 0.000 claims description 4
- 239000000395 magnesium oxide Substances 0.000 claims description 4
- 235000012245 magnesium oxide Nutrition 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 239000000419 plant extract Substances 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 4
- VIOYPGDQEDDCJB-UUCJDPIKSA-H trimagnesium;2-hydroxypropane-1,2,3-tricarboxylate;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound [Mg+2].[Mg+2].[Mg+2].C[N+](C)(C)C[C@H](O)CC([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VIOYPGDQEDDCJB-UUCJDPIKSA-H 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 241001494479 Pecora Species 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- -1 acyl L-carnitine hydrochloride Chemical compound 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 229960002713 calcium chloride Drugs 0.000 claims description 3
- 235000011148 calcium chloride Nutrition 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- AKGWUHIOEVNNPC-LURJTMIESA-N Arg-OEt Chemical compound CCOC(=O)[C@@H](N)CCCNC(N)=N AKGWUHIOEVNNPC-LURJTMIESA-N 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 claims description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 2
- 239000004227 calcium gluconate Substances 0.000 claims description 2
- 235000013927 calcium gluconate Nutrition 0.000 claims description 2
- 229960004494 calcium gluconate Drugs 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 229960002337 magnesium chloride Drugs 0.000 claims description 2
- 235000011147 magnesium chloride Nutrition 0.000 claims description 2
- 239000001755 magnesium gluconate Substances 0.000 claims description 2
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 2
- 229960003035 magnesium gluconate Drugs 0.000 claims description 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims description 2
- 239000004137 magnesium phosphate Substances 0.000 claims description 2
- 229960002261 magnesium phosphate Drugs 0.000 claims description 2
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims description 2
- 235000010994 magnesium phosphates Nutrition 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 2
- 239000011667 zinc carbonate Substances 0.000 claims description 2
- 235000004416 zinc carbonate Nutrition 0.000 claims description 2
- 229910000010 zinc carbonate Inorganic materials 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 235000005074 zinc chloride Nutrition 0.000 claims description 2
- 239000011746 zinc citrate Substances 0.000 claims description 2
- 235000006076 zinc citrate Nutrition 0.000 claims description 2
- 229940068475 zinc citrate Drugs 0.000 claims description 2
- 239000011670 zinc gluconate Substances 0.000 claims description 2
- 235000011478 zinc gluconate Nutrition 0.000 claims description 2
- 229960000306 zinc gluconate Drugs 0.000 claims description 2
- 239000011576 zinc lactate Substances 0.000 claims description 2
- 235000000193 zinc lactate Nutrition 0.000 claims description 2
- 229940050168 zinc lactate Drugs 0.000 claims description 2
- 239000011787 zinc oxide Substances 0.000 claims description 2
- 235000014692 zinc oxide Nutrition 0.000 claims description 2
- 239000000306 component Substances 0.000 claims 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims 1
- 239000001354 calcium citrate Substances 0.000 claims 1
- 229960004256 calcium citrate Drugs 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- 235000019504 cigarettes Nutrition 0.000 claims 1
- 239000005428 food component Substances 0.000 claims 1
- 239000010985 leather Substances 0.000 claims 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims 1
- 239000001095 magnesium carbonate Substances 0.000 claims 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims 1
- 229960001708 magnesium carbonate Drugs 0.000 claims 1
- 235000014380 magnesium carbonate Nutrition 0.000 claims 1
- 235000013337 tricalcium citrate Nutrition 0.000 claims 1
- 235000021419 vinegar Nutrition 0.000 claims 1
- 239000000052 vinegar Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 229940043825 zinc carbonate Drugs 0.000 claims 1
- 229960001939 zinc chloride Drugs 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000007812 deficiency Effects 0.000 abstract description 10
- 201000001881 impotence Diseases 0.000 abstract description 7
- 230000005906 menstruation Effects 0.000 abstract description 7
- 230000001568 sexual effect Effects 0.000 abstract description 7
- 206010036596 premature ejaculation Diseases 0.000 abstract description 5
- 230000009467 reduction Effects 0.000 abstract description 3
- 239000000284 extract Substances 0.000 description 37
- 230000000694 effects Effects 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 14
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 12
- 230000006872 improvement Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 241000207925 Leonurus Species 0.000 description 8
- JATPLOXBFFRHDN-DDWIOCJRSA-N [(2r)-2-acetyloxy-3-carboxypropyl]-trimethylazanium;chloride Chemical compound [Cl-].CC(=O)O[C@H](CC(O)=O)C[N+](C)(C)C JATPLOXBFFRHDN-DDWIOCJRSA-N 0.000 description 8
- 235000013339 cereals Nutrition 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229960003604 testosterone Drugs 0.000 description 7
- 235000016804 zinc Nutrition 0.000 description 7
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 235000019158 vitamin B6 Nutrition 0.000 description 6
- 239000011726 vitamin B6 Substances 0.000 description 6
- 229940011671 vitamin b6 Drugs 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 208000021267 infertility disease Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229940068063 damiana extract Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000004064 dysfunction Effects 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- RPFXMGGIQREZOH-ILKKLZGPSA-N ethyl (2s)-2-amino-5-(diaminomethylideneamino)pentanoate;dihydrochloride Chemical compound Cl.Cl.CCOC(=O)[C@@H](N)CCCN=C(N)N RPFXMGGIQREZOH-ILKKLZGPSA-N 0.000 description 4
- 208000000509 infertility Diseases 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 4
- 230000036299 sexual function Effects 0.000 description 4
- 239000011122 softwood Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 244000061520 Angelica archangelica Species 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- 241000893536 Epimedium Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000025844 Prostatic disease Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000018905 epimedium Nutrition 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 231100000535 infertility Toxicity 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229960005190 phenylalanine Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 230000035946 sexual desire Effects 0.000 description 3
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 description 2
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 2
- 206010036618 Premenstrual syndrome Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000819233 Tribulus <sea snail> Species 0.000 description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000000643 oven drying Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 229940047183 tribulus Drugs 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- 239000004246 zinc acetate Substances 0.000 description 2
- 235000013904 zinc acetate Nutrition 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 240000005739 Eurycoma longifolia Species 0.000 description 1
- 206010057671 Female sexual dysfunction Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 244000059675 Lindernia crustacea Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000030047 Sexual desire disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000009188 angelicae sinensis extract Substances 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- NEEHYRZPVYRGPP-IYEMJOQQSA-L calcium gluconate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O NEEHYRZPVYRGPP-IYEMJOQQSA-L 0.000 description 1
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical compound [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000009347 chasteberry Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000000709 neurohypophysis hormone Substances 0.000 description 1
- 208000018360 neuromuscular disease Diseases 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 208000024309 orgasm disease Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229940068189 posterior pituitary hormone Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009290 primary effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000008010 sperm capacitation Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 1
- 229960000317 yohimbine Drugs 0.000 description 1
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明实施例提供了一种适于男性的性保健食品,以重量份计,包含以下组分:高丽参1‑300份、淫羊藿1‑300份、育亨宾1‑300份、菟丝子籽1‑300份、肉苁蓉1‑400份、卡图巴1‑300份、东革阿里1‑300份、蒺藜1‑300份及锯棕榈浆果1‑600份。本发明实施例还提供了一种适于女性的性保健食品,其特征在于,以重量份计,包含以下组分:肉苁蓉1‑400份、巴西人参1‑300份、达米阿那1‑200份、圣洁莓1‑200份、当归1‑200份、益母草1‑300份及大豆异黄酮1‑60份。本发明实施例提供的适用于男性的性保健食品,可以有效的改善男性性功能障碍、精子数量减少、早泄、阳痿等症状;本发明实施例提供的适用于女性的性保健食品,可以改善女性的月经衍期,宫寒,气虚血虚等症状。
Description
技术领域
本发明涉及保健食品技术领域,特别是涉及一种适用于男性和女性的性保健食品。
背景技术
近几年越来越多的性健康(生殖健康)问题的出现,使性保健成为人们越来越关注的的话题。我国近年来不孕不育症存在着上升的趋势,适龄产妇的不孕不育患病率大幅增长。数据显示,国内不孕不育的平均发病率为12.5%~15%,也就是每8对夫妻就有一对不孕不育。
其中男性会出现不育、性功能障碍、前列腺等症状,精子数量减少,质量低下,性欲减退,早泄,阳痿等症状;女性的月经衍期,宫寒,不孕不育,气虚血虚等症状一直困扰着女性。
据统计40~70岁男子中有52%患有不同程度的性功能障碍。女性性功能障碍的发病率也很高,其中性欲和性高潮障碍最为普遍。
发明内容
本发明实施例的目的在于提供适用于男性和女性的性保健食品,用于改善目前常出现的男性性功能障碍、前列腺、不孕和/或女性的月经失调、宫寒不孕等问题。具体技术方案如下:
本发明第一方面提供了一种适于男性的性保健食品,以重量份计,包含以下组分:高丽参1-300份、淫羊藿1-300份、育亨宾1-300份、菟丝子籽1-300份、肉苁蓉1-400份、卡图巴1-300份、东革阿里1-300份、蒺藜1-300份及锯棕榈浆果1-600份。
其中,高丽参(Panax ginseng):一般特指朝鲜半岛产的红参。它通常用于恢复体力和精神,也有助于防止早泄。所述淫羊藿(Epimedium):最早它是由一些牧羊人发现的,他们注意到一些羊吃了这种草后,性活动明显增加,该草药因此而得名。淫羊藿是传统的中药补药,具有补阳肾,强盘骨,祛风湿,用于阳痿遗精,盘骨痿软,风湿痹痛麻木拘挛,更年期高血压症。育亨宾(Yohimbine):作用在阴茎血管,能使性器官血管扩充,增加性器官的血流量,增加一氧化二氮的形成,从而增强性功能。少量应用时,可使会阴部肿胀,刺激脊髓勃起中枢而使性功能亢进。对阳萎有一定治疗用。菟丝子籽(CuscutaChinensis seed):菟丝子通常称为菟丝子植物,其入药一般采用其种子,即菟丝子籽,用于增加精子数量和提高生育能力。新的研究表明,菟丝子尤其是菟丝子籽它还有助于治疗阳痿。肉苁蓉(Cistanchedeserticola):补肾阳,益精血,润肠道。主肾阳虚衰,精血不足之阳,遗精,白浊,尿频余沥,腰痛脚弱,耳鸣目花,月经衍期,宫寒不孕,肠燥便秘。蒺藜(Tribulus terrestrisL.):它的首要作用是通过恢复激素水平提高性欲,主要是睾丸激素。除了偶尔胃痛外,没有报告显示蒺藜有副作用。卡图巴(catuaba):这种物质可以为男性补充男性生殖器生长的必须物质-天然游离睾酮FT,卡图巴对以下三大症状具有功效(1)不育症(精子质量下降);(2)性功能障碍;(3)前列腺疾病。东革阿里(Eurycoma longifolia):研究表明东革阿里的增加提高精子含量,体积和活力,具体功效如下:(1)缓解糖尿病、高血糖、高血脂和高血压;(2)增强免疫力,提高身体机能,提神抗疲劳;(3)改善男性前列腺疾病,增强肾脏功能;(4)减轻痛风和风湿症状;(5)有清血功效,促进肝脏排毒和血液循环;(6)抗病毒作用,有抗癌作用;(7)提高男性睾酮素分泌,提高性能力。锯棕榈浆果(Saw palmetto):锯棕榈主要生长于美国气候温暖的东南部,例如南卡罗莱那、明尼苏达、密西西比到佛罗里达州一带;它常用于治疗泌尿系统问题,最常见的用途是使扩张的前列腺恢复正常大小;然而,大多数研究表明,长期使用(12个月或以上)锯棕榈也可以缓解排尿和显著提高性功能。尽管对这种草药有很多研究,但目前为止没有任何报告反映它有副作用,甚至连胃痛或腹泻的抱怨也没有。锯棕榈的浆果最早被美国印第安人用来治疗前列腺疾病及尿道感染,后来,德国人首次在防治前列腺肥大的药方中加入锯棕榈,大大提高了疗效,因此锯棕榈迅即风靡欧美。发明人将上述各具有药效的植物经合理配伍,制成本发明的适于男性的性保健食品。
在本发明第一方面的一种具体实施方式中,所述性保健食品,以重量份计,包含以下组分:高丽参5-20份、淫羊藿10-100份、育亨宾10-100份、菟丝子籽5-20份、肉苁蓉5-50份、卡图巴10-100份、东革阿里10-100份、蒺藜5-20份及锯棕榈浆果10-100份。
在本发明第一方面的另一种具体实施方式中,所述性保健食品,以重量份计,包含以下组分:高丽参10份、淫羊藿50份、育亨宾50份、菟丝子籽10份、肉苁蓉10份、卡图巴50份、东革阿里50份、蒺藜10份及锯棕榈浆果50份。
为了进一步增强上述的性保健食品对男性的保健作用,在第一方面提供的性保健食品中,以重量份计,还包含以下组分:巴西人参1-300份、达米阿那1-200份及圣洁莓1-200份。优选地,巴西人参10-100份、达米阿那10-100份及圣洁莓10-100份;更优选地,巴西人参50份、达米阿那50份及圣洁莓50份。
其中,巴西人参(Brazilian Ginseng):有明显缓解或治愈各种妇女病及更年期综合症;调理月经,经期不规律得到改善,经量增多,经期综合症减轻,甚至停经半年至一年的,也能重新来经;明显改善便秘症状;子宫肌瘤稳定、变小;有效激起性欲望。达米阿那(Damiana):这是壮阳药的一种,主要生长在中美洲和南美洲,其可激发男性荷尔蒙,提高性能力。圣洁莓(chaste berry):圣洁莓含有一种很类似人体黄体素的成份.可以发挥类似人体黄体素荷尔蒙的功能。保护乳房健康,缓解经前期不适。发明人外意地发现,将上述巴西人参、圣洁莓等对女性有益的物质加入到前述的适于男性的性保健食品中后,可以进一步加强性保健食品对于男性的性保健功效。
本发明第二方面提供了一种适于女性的性保健食品,以重量份计,包含以下组分:肉苁蓉1-400份、巴西人参1-300份、达米阿那1-200份、圣洁莓1-200份、当归1-200份、益母草1-300份及大豆异黄酮1-60份。
其中,当归(Angelica):当归具有补血活血,调经止痛,润肠通便,血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡的作用。益母草(Motherwort Herb P.E):用于月经不调、痛经闭经、恶露不绝、产后瘀血腹痛、肾炎浮肿、小便不利、疮疡肿毒、跌打损伤。益母草对子宫有明显的兴奋作用,使子宫肌的收缩显著增强,其作用与脑垂体后叶激素相似。大豆异黄酮(CatheRine Genistein):大豆异黄酮是一种植物性雌激素,又称为植物动情激素,是一种天然荷尔蒙,异黄酮是黄酮类化合物中的一种,主要存在于豆科植物中,是大豆生长中形成的一类次级代谢产物,提高女性性生活质量。植物雌激素是植物中具有弱雌激素作用的化合物。其通过与甾体雌激素受体以低亲和度结合而发挥弱的雌激素样效应,虽然被人们称为植物性雌激素,其实它们本身不是激素。发明人将上述各具有药效的植物经合理配伍,制成本发明的适于女性的性保健食品。
在本发明第二方面的一种具体实施方式中,所说的性保健食品以重量份计,包含以下组分:肉苁蓉5-50份、巴西人参10-100份、达米阿那10-100份、圣洁莓10-100份、当归10-50份、益母草10-100份及大豆异黄酮10-30份。
在本发明第二方面的另一种具体实施方式中,所说的性保健食品以重量份计,包含以下组分:肉苁蓉10份、巴西人参50份、达米阿那50份、圣洁莓50份、当归20份、益母草50份及大豆异黄酮20份。
为了进一步增强上述的性保健食品对女性的保健作用,在第二方面提供的性保健食品中,以重量份计,还包含以下组分:高丽参1-300份、淫羊藿1-300份、育亨宾1-300份及菟丝子籽1-300份优选地,高丽参5-20份、淫羊藿10-100份、育亨宾10-100份及菟丝子籽5-20份;更优选地,高丽参10份、淫羊藿50份、育亨宾50份及菟丝子籽10份。发明人发现,将上述的高丽参、淫羊藿、育亨宾、及菟丝子籽等应用于男性的组分加入到前述的适于女性的性保健食品中后,意外地可以进一步加强性保健食品对于女性的性保健功效。
在本发明第一方面及第二方面所提供的性保健食品的具体实施方案中,各组分可以选用各组分所对应的植物提取物。具体地,如蒺藜提取物、卡图巴提取物、东革阿里提取物、锯棕榈浆果提取物、高丽参提取物、淫羊藿提取物、育亨宾提取物、菟丝子籽提取物、肉苁蓉提取物、当归提取物、益母草提取物、巴西人参提取物、达米阿那提取物、圣洁莓提取物、大豆异黄酮提取物。需要说明的是,上述各植物提取物的提取方法均为已知技术,本领域技术人员根据现有的提取方法可以容易地获得上述各植物提取物,本发明在此对各植物提取物的提取方法不进行限定。
为了进一步提升本发明第一方面及第二方面所提供的性保健食品的保健作用,在前述各性保健食品所包含的组分的基础上,本发明提供的性保健食品还可以包含对人体有益的微量元素和氨基酸。
在一种具体实施方案中,以重量份计,可以包含烟酸10-50份、维生素B61-10份、锌元素1-10份、镁元素1-10份、钙元素5-20份、L-精氨酸乙酯二盐酸盐10-100份、L-苯丙氨酸10-30份、L-赖氨酸盐酸盐10-100份、左旋肉碱50-100份、乙酰左旋肉碱盐酸盐100-200份中的一种或其组合,优选至少两种或更多,更优选至少四种或更多,再优选至少6种或更多。
其中,所述锌元素由含锌的化合物提供,优选地,所述含锌的化合物选自甘氨酸锌、柠檬酸锌、葡萄糖酸锌、乳酸锌、氯化锌、碳酸锌、醋酸锌、氧化锌中的一种或其组合;所述镁元素由含镁的化合物提供,,优选地,所述含镁的化合物选自左旋肉碱柠檬酸镁、碳酸镁、氯化镁、葡萄糖酸镁、柠檬酸镁、磷酸镁、氧化镁、硫酸镁中的一种或其组合;所述钙元素由含钙的化合物提供,,优选地,所述含钙的化合物选自左旋肉碱富马酸钙、葡萄糖酸钙、柠檬酸钙、氯化钙、乳酸钙中的一种或其组合。
在所添加的微量元素和氨基酸中,烟酸在人体内转化为烟酰胺,参与体内脂质代谢,组织呼吸的氧化过程和糖类无氧分解的过程;因营养不良体重骤减,妊娠期、哺乳期,以及服用异烟肼者,严重烟瘾、酗酒、吸毒者,烟酸需要量均增加。维生素B6是人体脂肪和糖代谢的必需物质,女性的雌激素代谢也需要维生素B6,因此它对防治某些妇科病大有益处。左旋肉碱柠檬酸镁对人体激素有调节作用,能改善情绪低落,提升激情。甘氨酸锌:锌元素大量存在于男性睾丸中,参与精子的整个生成、成熟和获能的过程,维持男性正常的生精功能。左旋肉碱富马酸钙能协助人体神经系统,传递紧急的冲动信号。L-精氨酸乙酯二盐酸盐:精氨酸为一氧化氮生产的关键,一氧化氮对尿失禁、性功能障碍、阿尔茨海默病、甚至癌症等方面的效果良好,一氧化氮氧化扩张血管以改善血液流动,用于改善勃起质量。L-苯丙氨酸能降低饥饿,提高性欲,消除抑郁情绪,改善记忆及提高思维敏捷度。L-赖氨酸盐酸盐:赖氨酸在体内发挥着重要的生理功能,其缺乏将直接或间接影响动物的生长、繁殖和发育。赖氨酸与某些非甾体抗炎药结合,能够治疗与经前综合症和月经初潮相关的偏头痛和腹部绞痛。乙酰左旋肉碱盐酸盐:乙酰左旋肉碱是存在于体内的一种自然物质,尤其在肌肉、大脑及精子中含量特别丰富,在人体内参与一系列重要的代谢过程,它从细胞中带走乙酰基并协助能量转移。左旋肉碱:左旋肉碱的功效也有很多报道,左旋肉碱是一种重要的食品营养强化剂,已广泛应用于食品工业,如婴儿奶粉,减肥食品,运动员营养品和中老年营养补剂中以及饲料加工业中,此外还有医药方面的疗效,心血管疾病、肝脏疾病、肾脏疾病、高脂血症、糖尿病、神经肌肉疾病等均可通过服用左旋肉碱及其系列产品而使病症得到改善。乙酰左旋肉碱在中枢神经系统和男性生殖中起到重要作用。乙酰左旋肉碱和左旋肉碱合用治疗减弱精子症,可显著提高每次射精中前向运动精子和运动精子总数,提高女性临床妊娠率,安全有效。上述的这些微量元素及氨基酸均可以通过市售途径获得,或者通过现有技术来制备,本发明在此对这些微量元素及氨基酸的来源或制备方法不进行限定。
在本发明前述第一方面及第二方面所提供的性保健食品的具体实施方案中,所述性保健食品还可以包括药学上常规的辅料,所述辅料选自但不限于淀粉、硬脂酸镁、纤维素、二氧化硅、滑石粉、乳糖、糊精中的一种或其组合。
在本发明前述第一方面及第二方面所提供的性保健食品的具体实施方案中,所述性保健食品的剂型为片剂、颗粒剂、粉剂或胶囊剂。
本发明前述的性保健食品,可以通过将各组分按配比混合而成,然后按照药剂学常规制剂方法,可制备成胶囊、颗粒、片剂等各种剂型。
本发明实施例提供的适用于男性的性保健食品,可以有效的改善男性性功能障碍、精子数量减少、早泄、阳痿等症状;本发明实施例提供的适用于女性的性保健食品,可以改善女性的月经衍期,宫寒,气虚血虚等症状。
不仅如此,本发明实施例提供一种适用于男性和/或女性的性保健食品,其各组分基本上来源于天然植物原料,无毒副作用,安全性高。
具体实施方式
下面将结合具体实施例对本发明的技术方案进行描述,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1 制备适于男性的性保健食品(胶囊)
男性保健食品包括以下组份:甘氨酸锌17kg(锌5.2kg),左旋肉碱柠檬酸镁83.2kg(镁5.3kg),左旋肉碱富马酸钙113.4kg(钙10.5kg),乙酰左旋肉碱盐酸盐181.4kg,L-苯丙氨酸30kg,L-精氨酸乙酯二盐酸盐50kg,蒺藜10kg,卡图巴50kg,东革阿里50kg,高丽参10kg,淫羊藿50kg,育亨宾50kg,菟丝子籽10kg,肉苁蓉10kg,锯棕榈浆果50kg。
称取上述各组份,取重量较小的两组份先混合均匀,然后再加入重量稍重的第三组份混合均匀,依此类推,按照重量由小到大逐次进行混合,混匀,倒入胶囊填充模具中,刨光表面粉末,得到硬胶囊。
实施例2 制备适于男性的性保健食品(片剂)
男性保健食品包括以下组份:硫酸锌12.38kg(锌5kg),柠檬酸镁146kg(镁5kg),葡萄糖酸钙112kg(钙10kg),左旋肉碱78kg,乙酰左旋肉碱盐酸盐200kg,L-苯丙氨酸25kg,L-精氨酸乙酯二盐酸盐60kg,蒺藜15kg,卡图巴45kg,东革阿里40kg,高丽参15kg,淫羊藿45kg,育亨宾45kg,菟丝子籽15kg,肉苁蓉15kg,锯棕榈浆果45kg。
其制备过程如下:按上述重量称取各组分提取物,粉碎,混匀,以80%的乙醇溶液作为粘合剂,制得软材,过20目筛制得湿粒,将湿粒置于50-60℃烘箱干燥3-4h,过18目筛整粒,得干颗粒,加入二氧化硅作为润滑剂,混匀,于压片机中压片,得片剂。
实施例3 制备适于男性的性保健食品(颗粒剂)
本发明的男性保健食品包括以下组份:醋酸锌15.5kg(锌5.5kg),氧化镁9kg(镁5.5kg),氯化钙30.5kg(钙11kg),左旋肉碱80kg,乙酰左旋肉碱盐酸盐190kg,L-苯丙氨酸35kg,L-精氨酸乙酯二盐酸盐60kg,蒺藜20kg,卡图巴60kg,东革阿里40kg,高丽参20kg,淫羊藿65kg,育亨宾50kg,菟丝子籽15kg,肉苁蓉15kg,锯棕榈浆果45kg。
制备过程如下:按上述重量称取各个组份,粉碎,混匀,以80%的乙醇溶液作粘合剂,制得软材,过12目筛眼的YK-160型摇摆制粒机制粒,得湿颗粒。待酒精挥发完全后,将物料置于DPL-30型多功能制粒机中,在50℃沸腾干燥约1h,使终产品水分控制在5%以内。过筛,整粒,得颗粒剂。
实施例4 制备适于男性的性保健食品(胶囊)
实施例4与实施例1的区别在于:实施例4所包含的组分中还包含,巴西人参提取物50kg、达米阿那提取物50kg及圣洁莓提取物50kg。
实施例5 制备适于女性的性保健食品(胶囊)
女性保健食品包括以下组份:烟酸30kg,维生素B6 5kg,左旋肉碱柠檬酸镁83.2kg(镁5.3kg),左旋肉碱富马酸钙113.4kg(钙10.5kg),乙酰左旋肉碱盐酸盐181.4kg,L-赖氨酸盐酸盐50kg,当归提取物20kg,益母草提取物50kg,巴西人参提取物50kg,肉苁蓉提取物10kg,达米阿那提取物50kg,圣洁莓提取物50kg,大豆异黄酮提取物20kg。
称取上述组分,取重量较小的两组份先混合均匀,然后再加入重量稍重的第三组份混合均匀,依此类推,按照重量由小到大逐次进行混合,混匀,倒入胶囊填充模具中,刨光表面粉末,得到胶囊。
实施例6 制备适于女性的性保健食品(片剂)
女性保健食品包括以下组份:烟酸25kg,维生素B6 8kg,醋酸镁44.5kg(镁5kg),柠檬酸钙124.5kg(钙10kg),左旋肉碱78kg,乙酰左旋肉碱盐酸盐200kg,L-赖氨酸盐酸盐40kg,当归提取物30kg,益母草提取物40kg,巴西人参提取物50kg,肉苁蓉提取物55kg,达米阿那提取物40kg,圣洁莓提取物45kg,大豆异黄酮提取物20kg。
其制备过程如下:按上述重量称取各组分提取物,粉碎,混匀,以80%的乙醇溶液作为粘合剂,制得软材,过20目筛制得湿粒,将湿粒置于50-60℃烘箱干燥3-4h,过18目筛整粒,得干颗粒,加入二氧化硅作为润滑剂,混匀,于压片机中压片,得片剂。
实施例7 制备适于女性的性保健食品(颗粒剂)
女性保健食品包括以下组份:烟酸3kg,维生素B6 1kg,氧化镁9kg(镁5.5kg),碳酸钙27.5kg(钙11kg),左旋肉碱80kg,乙酰左旋肉碱盐酸盐190kg,L-赖氨酸盐酸盐55kg,当归提取物30kg,益母草提取物60kg,巴西人参提取物60kg,肉苁蓉提取物35kg,达米阿那提取物35kg,圣洁莓提取物50kg,大豆异黄酮提取物20kg。
制备过程如下:按上述重量称取各个组份,粉碎,混匀,以80%的乙醇溶液作粘合剂,制得软材,过12目筛眼的YK-160型摇摆制粒机制粒,得湿颗粒。待酒精挥发完全后,将物料置于DPL-30型多功能制粒机中,在50℃沸腾干燥约1h,使终产品水分控制在5%以内。过筛,整粒,得颗粒剂。
实施例8 制备适于女性的性保健食品(胶囊)
实施例8与实施例5的区别在于:实施例8的性保健食品所包含的组分中还包含高丽参提取物10kg、淫羊藿提取物50kg、育亨宾提取物50kg及菟丝子籽提取物10kg。
长期毒性试验
取ICR小鼠27只,30±2g,随机分为9组(每组3只),其中一组作为对照组(淀粉颗粒,按0.22g/30g体重);其余8组作为实验组(实施例1-8的性保健食品,按0.22g/30g体重),具体分别为实施例1组、实施例2组、实施例3组、实施例4组、实施例5组、实施例6组、实施例7组、实施例8组。给药3次/日,每周称一次体重,并根据体重调整给药量,连续给药30天。
小鼠给予本发明的性保健食品的剂量为22g/kg/日(临床成人拟用量的200倍),连续给药30天后,与对照组比较各项检测指标:精神状态、体重、食量、脏器系数等,未见明显的毒性敏感指标,停药恢复2周,小鼠各项检测指标均正常。实验结果表明长期食用对小鼠无明显毒副作用,对于成年人的拟用剂量处于安全范围。
临床效果试验
男性临床试验
将本发明实施例1-4制备的产品分别给予出现性功能障碍、精子数量减少、早泄、阳痿等症状的10位男性志愿者,给药3次/日,剂量为100mg/kg/日;连续给药30日后回访检测;结果发现,所有的男性对上述症状都有明显改善的感觉,并让所有男性志愿者对改善情况进行打分评价,满分为10分,其中,0分为没有改善,分数越高,改善越明显;各实施例的打分平均结果如表1所示;对所有男性志愿者进行验血检测,结果睾酮水平均比不服用前有所提高。各实施例的睾酮水平提高平均百分数如表1所示。
表1
实施例 | 实施例1 | 实施例2 | 实施例3 | 实施例4 |
症状改善评分 | 7 | 7.5 | 7.9 | 9 |
睾酮水平提高百分数 | 21.6% | 19.8% | 24.3% | 40.2% |
从表1中要以看出,本发明提供的适于男性的性保健食品,其效果明显,尤其是当性保健食品中包含有巴西人参、达米阿那及圣洁莓时,其对于男性性功能症状的改善以及睾酮水平的提高,均明显好于不包含巴西人参、达米阿那及圣洁莓的产品,这种效果非常出人预料。
女性临床试验
将本发明实施例5-8制备的产品分别给予10名出现月经衍期,宫寒,气虚血虚等症状的女性志愿者服用,给药3次/日,剂量为100mg/kg/日;连续给药30日后回访;结果发现,所有的女性对上述症状都有明显改善的感觉,并让所有女性志愿者对改善情况进行打分评价,满分为10分,其中,0分为没有改善,分数越高,改善越明显;各实施例的打分平均结果如表2所示;从表2中可以看出,本发明实施例5-8制备的产品,效果令人满意。
表2
实施例 | 实施例5 | 实施例6 | 实施例7 | 实施例8 |
症状改善评分 | 8.0 | 7.8 | 8.1 | 9.2 |
从表2中要以看出,本发明提供的适于女性的性保健食品,其效果明显,尤其是当性保健食品中包含有高丽参、淫羊藿、育亨宾及菟丝子籽时,其对于女性月经衍期,宫寒,气虚血虚等症状的改善,均明显好于不包含高丽参、淫羊藿、育亨宾及菟丝子籽的产品,这种效果非常出人预料。
以上对本发明所提供的适用于男性和女性的性保健食品进行了详细介绍。本文中应用了具体实施例对本发明的原理及实施方式进行了阐述,以上实施例的说明只是用于帮助理解本发明的方法及其中心思想。应当指出,对于本领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以对本发明进行若干改进和修饰,这些改进和修饰也落入本发明权利要求的保护。
Claims (10)
1.一种适于男性的性保健食品,其特征在于,以重量份计,包含以下组分:高丽参1-300份、淫羊藿1-300份、育亨宾1-300份、菟丝子籽1-300份、肉苁蓉1-400份、卡图巴1-300份、东革阿里1-300份、蒺藜1-300份及锯棕榈浆果1-600份;优选地,高丽参5-20份、淫羊藿10-100份、育亨宾10-100份、菟丝子籽5-20份、肉苁蓉5-50份、卡图巴10-100份、东革阿里10-100份、蒺藜5-20份及锯棕榈浆果10-100份;更优选地,高丽参10份、淫羊藿50份、育亨宾50份、菟丝子籽10份、肉苁蓉10份、卡图巴50份、东革阿里50份、蒺藜10份及锯棕榈浆果50份。
2.如权利要求1所述的性保健食品,其特征在于,以重量份计,还包含以下组分:巴西人参1-300份、达米阿那1-200份及圣洁莓1-200份;优选地,巴西人参10-100份、达米阿那10-100份及圣洁莓10-100份;更优选地,巴西人参50份、达米阿那50份及圣洁莓50份。
3.一种适于女性的性保健食品,其特征在于,以重量份计,包含以下组分:肉苁蓉1-400份、巴西人参1-300份、达米阿那1-200份、圣洁莓1-200份、当归1-200份、益母草1-300份及大豆异黄酮1-60份;优选地,肉苁蓉5-50份、巴西人参10-100份、达米阿那10-100份、圣洁莓10-100份、当归10-50份、益母草10-100份及大豆异黄酮10-30份;更优选地,肉苁蓉10份、巴西人参50份、达米阿那50份、圣洁莓50份、当归20份、益母草50份及大豆异黄酮20份。
4.如权利要求3所述的性保健食品,其特征在于,以重量份计,还包含以下组分:高丽参1-300份、淫羊藿1-300份、育亨宾1-300份及菟丝子籽1-300份;优选地,高丽参5-20份、淫羊藿10-100份、育亨宾10-100份及菟丝子籽5-20份;更优选地,高丽参10份、淫羊藿50份、育亨宾50份及菟丝子籽10份。
5.如权利要求1-4中任一项所述的性保健食品,其特征在于,性保健食品中所包含的各组分选用各组分所对应的植物提取物。
6.如权利要求1-4中任一项所述的性保健食品,其特征在于,所述性保健食品还包含微量元素和氨基酸。
7.如权利要求6所述的性保健食品,其特征在于,所述性保健食品以重量份计,包含烟酸10-50份、维生素B6 1-10份、锌元素1-10份、镁元素1-10份、钙元素5-20份、L-精氨酸乙酯二盐酸盐10-100份、L-苯丙氨酸10-30份、L-赖氨酸盐酸盐10-100份、左旋肉碱50-100份、乙酰左旋肉碱盐酸盐100-200份中的一种或其组合。
8.如权利要求7所述的性保健食品,其特征在于,所述锌元素由含锌的化合物提供,优选地,所述含锌的化合物选自甘氨酸锌、柠檬酸锌、葡萄糖酸锌、乳酸锌、氯化锌、碳酸锌、醋酸锌、氧化锌中的一种或其组合;所述镁元素由含镁的化合物提供,,优选地,所述含镁的化合物选自左旋肉碱柠檬酸镁、碳酸镁、氯化镁、葡萄糖酸镁、柠檬酸镁、磷酸镁、氧化镁、硫酸镁中的一种或其组合;所述钙元素由含钙的化合物提供,,优选地,所述含钙的化合物选自左旋肉碱富马酸钙、葡萄糖酸钙、柠檬酸钙、氯化钙、乳酸钙中的一种或其组合。
9.如权利要求1-4所述的性保健食品,其特征在于,所述性保健食品还包括辅料,优选地,所述辅料选自淀粉、硬脂酸镁、纤维素、二氧化硅、滑石粉、乳糖、糊精中的一种或其组合。
10.如权利要求1-4中任一项所述的性保健食品,其特征在于,所述性保健食品的剂型为片剂、颗粒剂、粉剂或胶囊剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710597992.4A CN109275903A (zh) | 2017-07-20 | 2017-07-20 | 适用于男性和女性的性保健食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710597992.4A CN109275903A (zh) | 2017-07-20 | 2017-07-20 | 适用于男性和女性的性保健食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109275903A true CN109275903A (zh) | 2019-01-29 |
Family
ID=65185042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710597992.4A Pending CN109275903A (zh) | 2017-07-20 | 2017-07-20 | 适用于男性和女性的性保健食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109275903A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113116898A (zh) * | 2021-04-20 | 2021-07-16 | 北京天玺宝科技有限公司 | 一种具有减肥功能的包含左卡尼汀或乙酰左卡尼汀和育亨宾的组合物及其应用 |
CN113812626A (zh) * | 2021-09-22 | 2021-12-21 | 无锡百荣生物科技有限公司 | 一种含复合植物提取物的功能补充剂及制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1426805A (zh) * | 2001-12-21 | 2003-07-02 | 游绍裘 | 有助于促进女性乳房丰满发育的保健食品 |
CN1785390A (zh) * | 2005-10-24 | 2006-06-14 | 李亚萍 | 治疗血虚型妇女性冷淡症的中草药汤剂及制备方法 |
CN101152199A (zh) * | 2006-09-27 | 2008-04-02 | 傅海洋 | 一种用于改善男、女性功能的保健食品 |
CN102000211A (zh) * | 2010-11-22 | 2011-04-06 | 张颖 | 一种用于改善睡眠、治疗阳痿、早泄的中药组合物及制剂方法 |
CN102578588A (zh) * | 2011-01-13 | 2012-07-18 | 中国科学院上海生命科学研究院 | 一种对运动和性机能有促进作用的组合物 |
CN105663454A (zh) * | 2014-11-21 | 2016-06-15 | 青岛加云华海健康科技有限公司 | 一种中药组合物及其制剂和其制备方法及用途 |
-
2017
- 2017-07-20 CN CN201710597992.4A patent/CN109275903A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1426805A (zh) * | 2001-12-21 | 2003-07-02 | 游绍裘 | 有助于促进女性乳房丰满发育的保健食品 |
CN1785390A (zh) * | 2005-10-24 | 2006-06-14 | 李亚萍 | 治疗血虚型妇女性冷淡症的中草药汤剂及制备方法 |
CN101152199A (zh) * | 2006-09-27 | 2008-04-02 | 傅海洋 | 一种用于改善男、女性功能的保健食品 |
CN102000211A (zh) * | 2010-11-22 | 2011-04-06 | 张颖 | 一种用于改善睡眠、治疗阳痿、早泄的中药组合物及制剂方法 |
CN102578588A (zh) * | 2011-01-13 | 2012-07-18 | 中国科学院上海生命科学研究院 | 一种对运动和性机能有促进作用的组合物 |
CN105663454A (zh) * | 2014-11-21 | 2016-06-15 | 青岛加云华海健康科技有限公司 | 一种中药组合物及其制剂和其制备方法及用途 |
Non-Patent Citations (8)
Title |
---|
(美)哈同著;王沙等译: "《我的草本生活》", 31 October 2012, 重庆出版社 * |
(英)葛兰威尔著;刘令仪等译: "《如何快速怀孕》", 31 May 2015, 天津科学技术出版社 * |
时月等: "《抗病王》", 30 September 2005, 广东经济出版社 * |
杨乃华: "《自然疗法大全》", 31 July 2016, 中医古籍出版社 * |
江鱼等: "《性医学》", 31 December 2000, 上海科技教育出版社 * |
袁昌齐等: "《世界植物药》", 31 January 2013, 东南大学出版社 * |
陈长勋: "《中药药理学 第2版》", 31 January 2015, 上海科学技术出版社 * |
马汴梁: "《女子用汤》", 30 April 2006, 科学技术文献出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113116898A (zh) * | 2021-04-20 | 2021-07-16 | 北京天玺宝科技有限公司 | 一种具有减肥功能的包含左卡尼汀或乙酰左卡尼汀和育亨宾的组合物及其应用 |
CN113812626A (zh) * | 2021-09-22 | 2021-12-21 | 无锡百荣生物科技有限公司 | 一种含复合植物提取物的功能补充剂及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103690919B (zh) | 用于治疗仔猪缺铁性贫血的药物及其制备方法 | |
CN104431586A (zh) | 一种仔猪配合饲料及其制备方法 | |
CN102895319A (zh) | 一种含苁蓉或锁阳或枸杞、南瓜子、花粉的组合物 | |
CN104116022B (zh) | 用于改善妇女更年期综合症的复合保健食品及其制备方法 | |
CN106938005A (zh) | 一种用于治疗骨质疏松的中药组合物 | |
CN106578537A (zh) | 一种防治产后炎症的哺乳母猪预混合饲料及其制备方法 | |
CN102846906A (zh) | 一种治疗卵巢早衰的药物及其制备方法 | |
CN105943958A (zh) | 一种治疗痛风的桦褐孔菌复合固体颗粒及其制备方法 | |
CN109275903A (zh) | 适用于男性和女性的性保健食品 | |
CN106668119A (zh) | 一种改善泌乳力的哺乳母猪预混合饲料及其制备方法 | |
KR101600751B1 (ko) | 녹용을 함유하는 여성 불임증 치료용 한약 조성물 제조 방법 | |
CN104970220A (zh) | 一种哺乳期母猪配合饲料及其制备方法 | |
CN104095192A (zh) | 一种治疗便秘的米糊 | |
Pal et al. | A review on post pregnancy healer herbs | |
CN104906526A (zh) | 一种用于卵巢早衰的中药制剂及其制备方法 | |
CN104547789A (zh) | 一种治疗气血虚弱型产后缺乳的中药及其制备方法 | |
CN103815348A (zh) | 一种刺玫果滋阴润燥火锅调料 | |
CN103689298B (zh) | 用于治疗僵猪的饲料及其制备方法 | |
CN103142751A (zh) | 治疗仔猪缺铁性贫血的中药组合物 | |
CN107913374A (zh) | 一种治疗结石的药物组合物及其制备方法 | |
CN106729409A (zh) | 一种用于儿童腹股沟疝护理的中药组合物 | |
CN104984119A (zh) | 一种母犬专用营养软膏及其制备方法 | |
CN103751343B (zh) | 一种治疗肾气不固证型肾病的中药 | |
CN105106533A (zh) | 一种治疗妊娠期胆结石的中药组合物 | |
CN104366606A (zh) | 妇产科保健鲫鱼汤及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190129 |